Lisez cet article à voix haute
Activez le micro et lisez à votre rythme. Les mots s’allument au fil de la lecture, et rien ne vous arrête quand l’un d’eux est mal prononcé.
Votre audio n’est jamais envoyé à MovaReader : c’est votre navigateur qui le reconnaît. Politique de confidentialité
Connectez-vous pour garder cette séance dans votre historique de lecture.
Biological Vector Control: Evaluating Public Health Field Trials in Yogyakarta
The burden of dengue fever has expanded dramatically across tropical urban environments over the past four decades. In response to the limitations of chemical insecticides, public health researchers have pioneered biological vector interventions. Among these, the release of mosquitoes infected with Wolbachia pipientis, an obligate intracellular bacterium, represents a paradigm shift. Although the microorganism occurs naturally in roughly half of all insect species, it does not naturally infect Aedes aegypti, the primary vector responsible for dengue, Zika, and chikungunya. Introducing this endosymbiont halts viral replication within the insect host. Consequently, such biological modifications prevent mosquitoes from transmitting pathogens to humans.
The underlying mechanism relies on a reproductive phenomenon known as cytoplasmic incompatibility. When uninfected females mate with infected males, the resulting eggs fail to hatch, whereas infected females reproduce successfully regardless of their mate's status.